Filed before 2025Filed 27 December 2023
Abata Therapeutics, Inc. raised $15.3M
Abata Therapeutics, Inc., a biotech company based in Watertown, MA, raised $15.3M in a new debt round, according to a filing dated 27 December 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 27 December 2023
- Round
- Debt round
- Amount sold
- $15.3M
- Offering size
- Open-ended
- Investors so far
- 8
- Based in
- Watertown, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
4 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 73% of the 1,396 tracked raises with an amount filed in 2023, and than 54% of the 142 in biotech.
Abata Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 27 Dec 2023 | New filing | $15.3M | This raise |
| 16 Jun 2022 | Amended filing | $45M | Another raise |
| 21 Jun 2021 | New filing | $45M | Another raise |
More with Ascenta Capital on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.